Biomedical Engineering Reference
In-Depth Information
20. Ishibuchi S, Morimoto H, Oe T, Ikebe T, Inoue H, Fukunari A, Kamezawa M, Yamada
I, Naka Y. 2001. Synthesis and structure-activity relationships of 1-phenylpyrazoles as
xanthine oxidase inhibitors. Bioorg Med Chem Lett 11:879-882.
21. Sai Y, Kato Y, Nakamura K, Kato S, Nishimura T, Kubo Y, Tamai I, Yang S, Hu Z, Yamada
I, Tsuji A. 2006. Carrier-mediated hepatic uptake of a novel nonrenal excretion type uric
acid generation inhibitor, Y-700. J Pharm Sci 95:336-347.
22. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi
A, Shoji Y, et al. 1999. Primary systemic carnitine deficiency is caused by mutations in a
gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
23. Ohashi R, Tamai I, Nezu J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji
A. 2001. Molecular and physiological evidence for multifunctionality of carnitine/organic
cation transporter OCTN2. Mol Pharmacol 59:358-366.
24. Naruhashi K, Tamai I, Inoue N, Muraoka H, Sai Y, Suzuki N, Tsuji A. 2002. Involvement
of multidrug resistance-associated protein2 in intestinal secretion of grepafloxacin in rats.
Antimicrob Agents Chemother 46:344-349.
25. Naruhashi K, Tamai I, Inoue N, Muraoka H, Sai Y, Suzuki N, Tsuji A. 2001. Active intestinal
secretion of new quinolone antimicrobials and the partial contribution of P-glycoprotein.
J Pharm Pharmacol 53:699-709.
26. Tamai I, Takanaga H, Maeda H, Yabuuchi H, Sai Y, Suzuki Y, Tsuji A. 1997. Intestinal
brush-border transport of monocarboxylic acids mediated by proton-coupled transport and
anion antiport mechanisms. J Pharm Pharmacol 49:108-112.
27. Tsuji A, Nakashima E, Kagami I, Honjo N, Yamana T. 1977. Effect of dose-concentration
on the absorption of amoxicillin and ampicillin from the rat intestine. J Pharm Pharmacol
29:707-708.
28. Nakashima E, Tsuji A, Mizuo H, Yamana T. 1984. Kinetics and mechanism of in vitro
uptake of amino-beta-lactam antibiotics by rat small intestine and relation to the intact-
peptide transport system. Biochem Pharmacol 33:3345-3352.
29. Shinkawa T, Yamasaki F, Notsu T, Nakakuki M, Nishijima K, Yoshitomi K, Imai M. 1993.
Loop and distal actions of a novel diuretic, M17055. Eur J Pharmacol 238:317-325.
30. Nishimura T, Kato Y, Sai Y, Ogihara T, Tsuji A. 2004. Characterization of renal excretion
mechanism for a novel diuretic, M17055, in rats. J Pharm Sci 93:2558-2566.
31. Baur H, Kasperek S, Pfaff E. 1975. Criteria of viability of isolated liver cells. Hoppe-Seyler
Z Physiol Chem 356: 827-838.
32. Moldeus P, Hogberg J, Orrenius S. 1978. Isolation and use of liver cells. Methods Enzymol
52:60-71.
33. Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A. 2003. Contribution of organic anion transporting
polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2,
D-Leu5]-enkephalin. J Pharm Pharmacol 55:1013-1020.
34. Tsuji A, Terasaki T, Tamai I, Nakashima E, Takanosu K. 1985. A carrier-mediated transport
system for benzylpenicillin in isolated hepatocytes. J Pharm Pharmacol 37:55-57.
35. Hashimoto N, Suzuki F, Tamai I, Nikaido H, Kuwajima M, Hayakawa J, Tsuji A. 1998.
Gene-dose effect on carnitine transport activity in embryonic fibroblasts of jvs mice as a
model of human carnitine transporter deficiency. Biochem Pharmacol 55:1729-1732.
36. Terasaki T, Hosoya K. 2001. Conditionally immortalized cell lines as a new in vitro model
for the study of barrier functions. Biol Pharm Bull 24:111-118.
Search WWH ::
Custom Search